Prof. Martin Schwab retires from ETH. In his farewell lecture he will review his scientific journey from the idea of neurite growth inhibition, via discovery of the inhibitory molecule to bedside therapy to enhance regeneration for spinal cord injury. He also founded the ZNZ in 1998.
Prof. Schwab will continue his research work at the Institute for Regenerative Medicine (IREM), University of Zurich and with UZH spin-off Novago Therapeutics AG
To learn more about Martin Schwab’s work watch this SCIENCEsuisse video that aired June 12, 2019 on SRF (in German)
Farewell lecture:
Title: The long way from bench to bedside for a regeneration enhancing therapy for spinal cord injury
Date: Monday, 02.12.2019, 5:15 pm
Place: ETH Zurich, Rämistrasse 101, Main building, F30 Auditorium Maximum